Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
Bibliographic Data
| ID | 15529147 |
|---|---|
| Authors | Artemis Zavaliangos‐Petropulu (0000-0003-1953-8663, University of California, Los Angeles, corresponding author), Artemis Zavaliangos-Petropulu, Shawn M Mcclintock (0000-0001-5372-0261, Southwestern Medical Center), Shantanu H Joshi (0000-0002-7292-8022, University of California, Los Angeles), Brandon Taraku (0000-0001-7998-1128, University of California, Los Angeles), Noor Al‐Sharif (0000-0003-3941-1416, University of California, Los Angeles), Noor B Al-Sharif, Randall Espinoza (0000-0003-2895-4212, University of California, Los Angeles), Randall T Espinoza, Katherine L Narr (0000-0002-9396-7936, University of California, Los Angeles) |
| Year | 2023 |
| Volume | 14 |
| Pages | 1227879-1227879 |
| Publication date | 2023-10-09 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1227879 |
| PMID | 37876623 |
| OpenAlex | W4387454900 |
| Language | EN |
| References cited | 72 |
These results provide new evidence to suggest that hippocampal subfield volumes at baseline may present a biomarker for neurocognitive improvement following ketamine treatment in TRD. In contrast, pre-treatment subfield volumes and changes in subfield volumes showed negligible relationships with ketamine-related improvements in depressive symptoms
Anesthesia · Antidepressant · Cognition · Depression (economics · Hippocampal formation · Hippocampus · Ketamine · Major depressive disorder · Neurocognitive · Psychiatry · Subiculum · Treatment-resistant depression · Functional Brain Connectivity Studies · Medicine · Psychology · Treatment of Major Depression · Tryptophan and brain disorders · Internal Medicine
| Highly cited | No |
|---|